Microbiol Immunol 2009, 53:206–215.PubMedCrossRef 11. Beutin L, Geier D, Steinruck H, Zimmermann S, Scheutz F: Prevalence and some properties of verotoxin (Shiga-like toxin)-producing Escherichia coli in seven different species of healthy domestic animals.

J Clin Microbiol 1993, 31:2483–2488.PubMedCentralPubMed 12. Elder RO, Keen JE, Siragusa GR, Barkocy-Gallagher GA, Koohmaraie M, Laegreid WW: Correlation of enterohemorrhagic Escherichia coli O157 prevalence in feces, hides, and carcasses of beef cattle during processing. Proc Natl Acad Sci U S A 2000, 97:2999–3003.PubMedCentralPubMedCrossRef 13. Clark CG, Johnson ST, Easy RH, Campbell JL, Rodgers FG: PCR for Dasatinib price detection of cdt-III and the relative frequencies of Cytolethal distending toxin variant-producing

Escherichia coli isolates from humans and cattle. J Clin Microbiol 2002, 40:2671–2674.PubMedCentralPubMedCrossRef 14. da Silva selleck inhibitor AS, da Silva LD: Investigation of putative CDT gene in Escherichia coli isolates from pigs with diarrhea. Vet Microbiol 2002, 89:195–199.PubMedCrossRef 15. Foster G, Ross HM, Pennycott TW, Ulixertinib supplier Hopkins GF, McLaren IM: Isolation of Escherichia coli O86:K61 producing cyto-lethal distending toxin from wild birds of the finch family. Lett Appl Microbiol 1998, 26:395–398.PubMedCrossRef 16. Mainil JG, Jacquemin E, Oswald E: Prevalence and identity of cdt-related sequences in necrotoxigenic Escherichia coli . Vet Microbiol 2003, 94:159–165.PubMedCrossRef 17. Friedrich AW, Lu S, Bielaszewska M, Prager R, Bruns P, Xu JG, Tschäpe H, Karch H: Cytolethal distending toxin in Escherichia coli O157:H7: spectrum of conservation, structure, and endothelial toxicity. J Clin Microbiol 2006, 44:1844–1846.PubMedCentralPubMedCrossRef 18. Abbott SL, O’Connor J, Robin T, Zimmer BL, Janda JM: Biochemical properties of a newly described Escherichia species, Escherichia albertii . J Clin Microbiol 2003, 41:4852–4854.PubMedCentralPubMedCrossRef 19. Ooka T, Seto K, Kawano K,

Kobayashi H, Etoh Y, Ichihara S, Kaneko A, Isobe J, Yamaguchi K, Horikawa K, Gomes TA, Linden A, Bardiau M, Mainil JG, Beutin L, Ogura Y, Hayashi T: Clinical significance of Escherichia albertii . Emerg Infec Dis 2012, 18:488–492.CrossRef 20. Pérès SY, Marchès O, Daigle F, Nougayrède JP, Herault F, Tasca C, De Rycke OSBPL9 J, Oswald E: A new cytolethal distending toxin (CDT) from Escherichia coli producing CNF2 blocks HeLa cell division in G2/M phase. Mol Microbiol 1997, 24:1095–1107.PubMedCrossRef 21. Paton AW, Srimanote P, Talbot UM, Wang H, Paton JC: A new family of potent AB(5) cytotoxins produced by Shiga toxigenic Escherichia coli . J Exp Med 2004, 200:35–46.PubMedCentralPubMedCrossRef 22. Wu Y, Hinenoya A, Taguchi T, Nagita A, Shima K, Tsukamoto T, Sugimoto N, Asakura M, Yamasaki S: Distribution of virulence genes related to adhesins and toxins in shiga toxin-producing Escherichia coli strains isolated from healthy cattle and diarrheal patients in Japan.